Dr. Reddy's Laboratories intends to introduce a more affordable generic version of Novo Nordisk's popular weight-loss ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Amgen AMGN and Novo Nordisk NVO are among the largest companies in the pharmaceutical space. Amgen boasts one of the largest portfolios in the sector, with a strong presence in oncology, ...

Older adults and women using Wegovy for obesity management may be more likely to lose lean mass, although increasing protein intake may help protect against lean mass loss, according to a speaker.

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side effects.

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expirations of blockbuster drugs. Pharmaceutical giants are ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...